The recent advances in proteomic instrumentation, methods and informatics have created exciting opportunities in all fields of diabetes research. The information on protein identification and structure provided by mass spectrometry is applicable to nearly all aspects of diabetes and its complications. Mass spectrometry-based proteomics has accelerated the identification of posttranslational modifications, including phosphorylation-site mapping, identification of protein-protein interactions, and changes in protein abundance or compartmentalization, just to name a few examples. However, the rapid rates of growth and change in proteomic technologies have also led to challenges in the translation and availability of these technologies to researchers, from new postdoctoral research fellows to established investigators who are not directly involved in this field. Although many of the fundamental principles of mass spectrometry are relatively straightforward, successful mass spectrometry-based proteomic analysis requires the combination of appropriate experimental design, access to state-of-the-art instrumentation, rigorous analysis of spectral data, and for some studies, bioinformatics tools to manage and interpret large datasets. Indeed, mass spectrometry-based proteomics is a multi-step process, and study design, from the perspectives of mass spectrometry data acquisition and interpretation, plays an important role in experimental success. The overall objective of the Proteomics Core is to provide Joslin researchers with assistance through the workflow of proteomics studies, including experimental design, sample preparation, mass spectrometric analysis, data analysis and interpretation, and bioinformatic tools. The specific objectives of Joslin's Proteomics Core are the following: 1) To assist and provide training in experimental design for proteomics studies. 2) To provide routine and custom mass spectroscopy-based proteomic analyses. 3) To assist with mass spectra analysis, interpretation, and database matching. 4) To develop a results database and incorporate access to bioinformatic tools for the analysis of proteomics data into the results database.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK036836-24
Application #
8060626
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
24
Fiscal Year
2010
Total Cost
$133,310
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Solheim, Marie H; Winnay, Jonathon N; Batista, Thiago M et al. (2018) Mice Carrying a Dominant-Negative Human PI3K Mutation Are Protected From Obesity and Hepatic Steatosis but Not Diabetes. Diabetes 67:1297-1309
Stanford, Kristin I; Lynes, Matthew D; Takahashi, Hirokazu et al. (2018) 12,13-diHOME: An Exercise-Induced Lipokine that Increases Skeletal Muscle Fatty Acid Uptake. Cell Metab 27:1111-1120.e3
McGill, Dayna E; Volkening, Lisa K; Butler, Deborah A et al. (2018) Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes. Diabetes Technol Ther 20:434-439
Weir, Gordon C; Ehlers, Mario R; Harris, Kristina M et al. (2018) Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics. Pediatr Diabetes 19:945-954
Qi, Weier; Li, Qian; Gordin, Daniel et al. (2018) Preservation of renal function in chronic diabetes by enhancing glomerular glucose metabolism. J Mol Med (Berl) 96:373-381
Adachi, Yusuke; De Sousa-Coelho, Ana Luisa; Harata, Ikue et al. (2018) l-Alanine activates hepatic AMP-activated protein kinase and modulates systemic glucose metabolism. Mol Metab 17:61-70
Berkowitz, Robert I; Marcus, Marsha D; Anderson, Barbara J et al. (2018) Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial. Pediatr Diabetes 19:191-198
Musen, Gail; Tinsley, Liane J; Marcinkowski, Katrina A et al. (2018) Cognitive Function Deficits Associated With Long-Duration Type 1 Diabetes and Vascular Complications. Diabetes Care 41:1749-1756
Shah, Hetal S; Morieri, Mario Luca; Marcovina, Santica M et al. (2018) Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD. Diabetes Care 41:348-355
Stanford, Kristin I; Lynes, Matthew D; Takahashi, Hirokazu et al. (2018) 12,13-diHOME: An Exercise-Induced Lipokine that Increases Skeletal Muscle Fatty Acid Uptake. Cell Metab 27:1357

Showing the most recent 10 out of 1120 publications